CLINICAL_TRIALS
trial_result
· 2026-04-01
Clinical Trial Update: PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study [Phase 2]
Summary
The PrecISE Network Phase 2 study in severe and/or exacerbation-prone asthma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2026-04-01